MKS Instruments, Inc. (NASDAQ:MKSI) has been assigned a consensus recommendation of “Buy” from the eleven analysts that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and ten have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $112.11.

A number of equities analysts recently commented on MKSI shares. Zacks Investment Research lowered MKS Instruments from a “hold” rating to a “sell” rating and set a $94.00 price objective on the stock. in a research note on Thursday, July 25th. BidaskClub raised MKS Instruments from a “hold” rating to a “buy” rating in a research note on Wednesday. Finally, ValuEngine raised MKS Instruments from a “hold” rating to a “buy” rating in a research note on Tuesday, August 6th.

Shares of NASDAQ MKSI traded down $1.05 during trading hours on Friday, hitting $93.49. The company had a trading volume of 368,342 shares, compared to its average volume of 559,922. The stock has a market capitalization of $4.97 billion, a P/E ratio of 11.94, a price-to-earnings-growth ratio of 1.88 and a beta of 1.46. The company has a quick ratio of 3.12, a current ratio of 4.80 and a debt-to-equity ratio of 0.48. MKS Instruments has a 1-year low of $56.37 and a 1-year high of $103.86. The firm’s 50 day moving average is $80.07 and its 200-day moving average is $83.00.

MKS Instruments (NASDAQ:MKSI) last issued its quarterly earnings results on Tuesday, July 30th. The scientific and technical instruments company reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.01. MKS Instruments had a return on equity of 16.34% and a net margin of 11.41%. The company had revenue of $474.11 million for the quarter, compared to analysts’ expectations of $483.27 million. During the same quarter last year, the business earned $2.33 earnings per share. MKS Instruments’s revenue was down 17.3% on a year-over-year basis. On average, sell-side analysts predict that MKS Instruments will post 4.03 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Monday, August 26th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 0.86%. The ex-dividend date of this dividend was Friday, August 23rd. MKS Instruments’s dividend payout ratio (DPR) is presently 10.22%.

In other MKS Instruments news, Director Jacqueline F. Moloney sold 603 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $81.98, for a total value of $49,433.94. Following the transaction, the director now directly owns 7,692 shares of the company’s stock, valued at $630,590.16. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.24% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Invesco Ltd. grew its holdings in MKS Instruments by 171.9% during the second quarter. Invesco Ltd. now owns 1,489,870 shares of the scientific and technical instruments company’s stock worth $116,046,000 after buying an additional 941,917 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in MKS Instruments by 70.6% during the first quarter. JPMorgan Chase & Co. now owns 1,214,934 shares of the scientific and technical instruments company’s stock worth $113,050,000 after buying an additional 502,758 shares in the last quarter. Ceredex Value Advisors LLC bought a new stake in MKS Instruments during the first quarter worth $28,115,000. First Trust Advisors LP grew its holdings in MKS Instruments by 760.5% during the second quarter. First Trust Advisors LP now owns 319,605 shares of the scientific and technical instruments company’s stock worth $24,894,000 after buying an additional 282,464 shares in the last quarter. Finally, OppenheimerFunds Inc. grew its stake in MKS Instruments by 38.6% in the 1st quarter. OppenheimerFunds Inc. now owns 893,041 shares of the scientific and technical instruments company’s stock valued at $83,098,000 after purchasing an additional 248,736 shares during the period. Hedge funds and other institutional investors own 96.95% of the company’s stock.

MKS Instruments Company Profile

MKS Instruments, Inc provides instruments, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. It operates through two segments, Vacuum and Analysis, and Light and Motion. The Vacuum and Analysis segment offers analytical and control solutions, including gas analyzers, automation control products, I/O modules, automation software, and precision machined components and electromechanical assemblies; direct and indirect pressure measurement and integrated process solutions; and materials delivery solutions comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems to provide customers with control capabilities that are optimized for a given application.

Read More: What is the Bid-Ask Spread?

Analyst Recommendations for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.